{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T01:49:06Z","timestamp":1774921746535,"version":"3.50.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003088","name":"Evangelisches Studienwerk Villigst","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003088","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004569","name":"Ministerstwo Edukacji i Nauki","doi-asserted-by":"publisher","award":["002 \/ RID \/ 2018\/19"],"award-info":[{"award-number":["002 \/ RID \/ 2018\/19"]}],"id":[{"id":"10.13039\/501100004569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.jchromb.2021.122891","type":"journal-article","created":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T12:08:29Z","timestamp":1628165309000},"page":"122891","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Mass spectrometry-based targeted proteomics method for the quantification of clinically relevant drug metabolizing enzymes in human specimens"],"prefix":"10.1016","volume":"1180","author":[{"given":"Christoph","family":"Wenzel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Drozdzik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Oswald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2021.122891_b0005","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1080\/10837450902891295","article-title":"Drug metabolism and pharmacokinetics","volume":"41","author":"Benedetti","year":"2009","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.jchromb.2021.122891_b0010","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0031-6997(24)01402-9","article-title":"Is the role of the small intestine in first-pass metabolism overemphasized?","volume":"51","author":"Lin","year":"1999","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jchromb.2021.122891_b0015","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s40262-015-0351-6","article-title":"Predicting drug extraction in the human gut wall: assessing contributions from drug metabolizing enzymes and transporter proteins using preclinical models","volume":"55","author":"Peters","year":"2016","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jchromb.2021.122891_b0020","doi-asserted-by":"crossref","first-page":"694","DOI":"10.2174\/138920007782109788","article-title":"The role of the intestine in drug metabolism and pharmacokinetics: an industry perspective","volume":"8","author":"Fisher","year":"2007","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.jchromb.2021.122891_b0025","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/cpt.967","article-title":"Protein Abundance of Clinically Relevant Drug-Metabolizing Enzymes in the Human Liver and Intestine: A Comparative Analysis in Paired Tissue Specimens","volume":"104","author":"Drozdzik","year":"2018","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jchromb.2021.122891_b0030","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jpba.2014.08.016","article-title":"Absolute protein quantification of clinically relevant cytochrome P450 enzymes and UDP-glucuronosyltransferases by mass spectrometry-based targeted proteomics","volume":"100","author":"Gr\u00f6er","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2021.122891_b0035","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jchromb.2021.122891_b0040","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1124\/dmd.108.025569","article-title":"Metabolism and excretion of rivaroxaban, an oral, direct factor Xa inhibitor, in rats, dogs, and humans","volume":"37","author":"Weinz","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jchromb.2021.122891_b0045","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1124\/dmd.108.025551","article-title":"In vitro metabolism of rivaroxaban, an oral, direct factor Xa inhibitor, in liver microsomes and hepatocytes of rats, dogs, and humans","volume":"37","author":"Lang","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jchromb.2021.122891_b0050","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s11239-011-0551-3","article-title":"Preclinical discovery of apixaban, a direct and orally bioavailable factor Xa inhibitor","volume":"31","author":"Wong","year":"2011","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.jchromb.2021.122891_b0055","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1124\/dmd.108.023143","article-title":"Apixaban metabolism and pharmacokinetics after oral administration to humans","volume":"37","author":"Raghavan","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jchromb.2021.122891_b0060","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1124\/dmd.108.025981","article-title":"Comparative metabolism of 14C-labeled apixaban in mice, rats, rabbits, dogs, and humans","volume":"37","author":"Zhang","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jchromb.2021.122891_b0065","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1124\/dmd.107.019083","article-title":"The metabolism and disposition of the oral direct thrombin inhibitor, dabigatran, in humans","volume":"36","author":"Blech","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jchromb.2021.122891_b0070","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11239-013-0929-5","article-title":"Pharmacology of the new target-specific oral anticoagulants","volume":"36","author":"Cabral","year":"2013","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.jchromb.2021.122891_b0075","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1124\/dmd.105.008672","article-title":"The human intestinal cytochrome P450 \u201cpie\u201d","volume":"34","author":"Paine","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jchromb.2021.122891_b0080","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0022-3565(25)22379-5","article-title":"Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians","volume":"270","author":"Shimada","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jchromb.2021.122891_b0085","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1074\/mcp.M700163-MCP200","article-title":"Isotope-labeled protein standards: toward absolute quantitative proteomics","volume":"6","author":"Brun","year":"2007","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.jchromb.2021.122891_b0090","doi-asserted-by":"crossref","first-page":"6940","DOI":"10.1073\/pnas.0832254100","article-title":"Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS","volume":"100","author":"Gerber","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jchromb.2021.122891_b0095","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jpba.2019.05.006","article-title":"Development and validation of an absolute protein assay for the simultaneous quantification of fourteen CYP450s in human microsomes by HPLC-MS\/MS-based targeted proteomics","volume":"173","author":"Grangeon","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2021.122891_b0100","article-title":"Quantification of proteins involved in intestinal epithelial handling of xenobiotics","author":"Al-Majdoub","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jchromb.2021.122891_b0105","doi-asserted-by":"crossref","DOI":"10.1021\/acs.molpharmaceut.0c00559","article-title":"Characterization of differential tissue abundance of major non-cyp enzymes in human","author":"Basit","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jchromb.2021.122891_b0110","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1111\/liv.14452","article-title":"Cell-type-resolved proteomic analysis of the human liver","volume":"40","author":"\u00d6lander","year":"2020","journal-title":"Liver Int."},{"key":"10.1016\/j.jchromb.2021.122891_b0115","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1021\/acs.molpharmaceut.8b00941","article-title":"Quantification of Proteins Involved in Drug Metabolism and Disposition in the Human Liver Using Label-Free Global Proteomics","volume":"16","author":"Couto","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jchromb.2021.122891_b0120","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1124\/dmd.118.080523","article-title":"Abundance of Phase 1 and 2 Drug-Metabolizing Enzymes in Alcoholic and Hepatitis C Cirrhotic Livers: A Quantitative Targeted Proteomics Study","volume":"46","author":"Prasad","year":"2018","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jchromb.2021.122891_b0125","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1124\/dmd.113.056291","article-title":"Optimized methods for targeted peptide-based quantification of human uridine 5'-diphosphate-glucuronosyltransferases in biological specimens using liquid chromatography-tandem mass spectrometry","volume":"42","author":"Sato","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jchromb.2021.122891_b0130","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.1021\/pr4004213","article-title":"Targeted quantitative proteomics for the analysis of 14 UGT1As and -2Bs in human liver using NanoUPLC-MS\/MS with selected reaction monitoring","volume":"12","author":"Fallon","year":"2013","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.jchromb.2021.122891_b0135","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1021\/ac201704a","article-title":"Quantification of human uridine-diphosphate glucuronosyl transferase 1A isoforms in liver, intestine, and kidney using nanobore liquid chromatography-tandem mass spectrometry","volume":"84","author":"Harbourt","year":"2012","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2021.122891_b0140","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/cpt.819","article-title":"Critical Issues and Optimized Practices in Quantification of Protein Abundance Level to Determine Interindividual Variability in DMET Proteins by LC-MS\/MS Proteomics","volume":"103","author":"Bhatt","year":"2018","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jchromb.2021.122891_b0145","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1124\/dmd.113.055632","article-title":"Simultaneous quantification of the abundance of several cytochrome P450 and uridine 5'-diphospho-glucuronosyltransferase enzymes in human liver microsomes using multiplexed targeted proteomics","volume":"42","author":"Achour","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jchromb.2021.122891_b0150","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1021\/acs.chemrestox.8b00413","article-title":"Highly Variable Expression of CYP1A1 in Human Liver and Impact on Pharmacokinetics of Riociguat and Granisetron in Humans","volume":"32","author":"Lang","year":"2019","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.jchromb.2021.122891_b0155","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1039\/C6SC03970G","article-title":"A practical strategy to design and develop an isoform-specific fluorescent probe for a target enzyme: CYP1A1 as a case study","volume":"8","author":"Dai","year":"2017","journal-title":"Chem. Sci."},{"key":"10.1016\/j.jchromb.2021.122891_b0160","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1124\/dmd.120.090480","article-title":"Enrichment-free High-throughput Liquid Chromatography-Multiple-Reaction Monitoring Quantification of Cytochrome P450 Proteins in Plated Human Hepatocytes Direct from 96-Well Plates Enables Routine Protein Induction Measurements","volume":"48","author":"Savaryn","year":"2020","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jchromb.2021.122891_b0165","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1124\/jpet.116.237594","article-title":"Predictors of Variation in CYP2A6 mRNA, Protein, and Enzyme Activity in a Human Liver Bank: Influence of Genetic and Nongenetic Factors","volume":"360","author":"Tanner","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jchromb.2021.122891_b0170","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1039\/C4AN02092H","article-title":"A new sample preparation method for the absolute quantitation of a target proteome using (18)O labeling combined with multiple reaction monitoring mass spectrometry","volume":"140","author":"Li","year":"2015","journal-title":"Analyst"},{"key":"10.1016\/j.jchromb.2021.122891_b0175","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/tpj.2015.58","article-title":"Interindividual variability of CYP2C19-catalyzed drug metabolism due to differences in gene diplotypes and cytochrome P450 oxidoreductase content","volume":"16","author":"Shirasaka","year":"2016","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.jchromb.2021.122891_b0180","doi-asserted-by":"crossref","first-page":"5329","DOI":"10.1038\/s41598-020-62174-w","article-title":"CYP2J2 Modulates Diverse Transcriptional Programs in Adult Human Cardiomyocytes","volume":"10","author":"Evangelista","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jchromb.2021.122891_b0185","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1124\/dmd.113.053801","article-title":"Targeted precise quantification of 12 human recombinant uridine-diphosphate glucuronosyl transferase 1A and 2B isoforms using nano-ultra-high-performance liquid chromatography\/tandem mass spectrometry with selected reaction monitoring","volume":"41","author":"Fallon","year":"2013","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jchromb.2021.122891_b0190","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/jps.22255","article-title":"Simultaneous absolute quantification of 11 cytochrome P450 isoforms in human liver microsomes by liquid chromatography tandem mass spectrometry with in silico target peptide selection","volume":"100","author":"Kawakami","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jchromb.2021.122891_b0195","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1002\/pmic.200800680","article-title":"Mass spectrometry-based absolute quantification of microsomal cytochrome P450 2D6 in human liver","volume":"9","author":"Langenfeld","year":"2009","journal-title":"Proteomics"},{"key":"10.1016\/j.jchromb.2021.122891_b0200","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1124\/dmd.111.042259","article-title":"Simultaneous absolute protein quantification of transporters, cytochromes P450, and UDP-glucuronosyltransferases as a novel approach for the characterization of individual human liver: comparison with mRNA levels and activities","volume":"40","author":"Ohtsuki","year":"2012","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jchromb.2021.122891_b0205","doi-asserted-by":"crossref","first-page":"5934","DOI":"10.1021\/pr400279u","article-title":"Alternative fusion protein strategies to express recalcitrant QconCAT proteins for quantitative proteomics of human drug metabolizing enzymes and transporters","volume":"12","author":"Russell","year":"2013","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.jchromb.2021.122891_b0210","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1002\/jps.22591","volume":"100","author":"Sakamoto","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jchromb.2021.122891_b0215","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3109\/00498254.2012.665950","article-title":"Protein quantification of UDP-glucuronosyltransferases 1A1 and 2B7 in human liver microsomes by LC-MS\/MS and correlation with glucuronidation activities","volume":"42","author":"Sato","year":"2012","journal-title":"Xenobiotica"},{"key":"10.1016\/j.jchromb.2021.122891_b0220","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1124\/dmd.111.042275","article-title":"Absolute quantification and differential expression of drug transporters, cytochrome P450 enzymes, and UDP-glucuronosyltransferases in cultured primary human hepatocytes","volume":"40","author":"Schaefer","year":"2012","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jchromb.2021.122891_b0225","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1021\/pr800795r","article-title":"Multiple-approaches to the identification and quantification of cytochromes P450 in human liver tissue by mass spectrometry","volume":"8","author":"Seibert","year":"2009","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.jchromb.2021.122891_b0230","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.1002\/pmic.200800144","article-title":"A gel-free MS-based quantitative proteomic approach accurately measures cytochrome P450 protein concentrations in human liver microsomes","volume":"8","author":"Wang","year":"2008","journal-title":"Proteomics"},{"key":"10.1016\/j.jchromb.2021.122891_b0235","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/pmic.201000456","article-title":"Quantitative protein determination for CYP induction via LC-MS\/MS","volume":"11","author":"Williamson","year":"2011","journal-title":"Proteomics"},{"key":"10.1016\/j.jchromb.2021.122891_b0240","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1124\/dmd.108.024166","article-title":"Quantitation of human cytochrome P450 2D6 protein with immunoblot and mass spectrometry analysis","volume":"37","author":"Yu","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jchromb.2021.122891_b0245","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1074\/mcp.M700132-MCP200","article-title":"High Sensitivity Detection of Plasma Proteins by Multiple Reaction Monitoring of N -Glycosites","volume":"6","author":"Stahl-Zeng","year":"2007","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.jchromb.2021.122891_b0250","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1124\/dmd.117.078626","article-title":"Direct Quantification of Cytochromes P450 and Drug Transporters-A Rapid, Targeted Mass Spectrometry-Based Immunoassay Panel for Tissues and Cell Culture Lysates","volume":"46","author":"Wei\u00df","year":"2018","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jchromb.2021.122891_b0255","doi-asserted-by":"crossref","first-page":"8759","DOI":"10.1038\/srep08759","article-title":"Indirect protein quantification of drug-transforming enzymes using peptide group-specific immunoaffinity enrichment and mass spectrometry","volume":"5","author":"Wei\u00df","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jchromb.2021.122891_b0260","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1124\/dmd.120.090738","article-title":"Regional Proteomic Quantification of Clinically Relevant Non-Cytochrome P450 Enzymes along the Human Small Intestine","volume":"48","author":"Zhang","year":"2020","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jchromb.2021.122891_b0265","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1021\/acs.molpharmaceut.7b00772","article-title":"High Expression of UGT1A1\/1A6 in Monkey Small Intestine: Comparison of Protein Expression Levels of Cytochromes P450, UDP-Glucuronosyltransferases, and Transporters in Small Intestine of Cynomolgus Monkey and Human","volume":"15","author":"Akazawa","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jchromb.2021.122891_b0270","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0090-9556(24)15229-4","article-title":"Characterization of human small intestinal cytochromes P-450","volume":"27","author":"Zhang","year":"1999","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jchromb.2021.122891_b0275","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1021\/acs.molpharmaceut.7b00364","article-title":"Variability in Mass Spectrometry-based Quantification of Clinically Relevant Drug Transporters and Drug Metabolizing Enzymes","volume":"14","author":"Wegler","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jchromb.2021.122891_b0280","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.xphs.2020.10.034","article-title":"Dilemmas With Absolute Quantification of Pharmacologically Relevant Proteins Using Mass Spectrometry","volume":"110","author":"Wi\u015bniewski","year":"2021","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jchromb.2021.122891_b0285","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/cpt.1537","article-title":"Toward a Consensus on Applying Quantitative Liquid Chromatography-Tandem Mass Spectrometry Proteomics in Translational Pharmacology Research: A White Paper","volume":"106","author":"Prasad","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jchromb.2021.122891_b0290","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bcp.2018.08.003","article-title":"Quantitative characterization of UDP-glucuronosyltransferase 2B17 in human liver and intestine and its role in testosterone first-pass metabolism","volume":"156","author":"Zhang","year":"2018","journal-title":"Biochem. Pharmacol."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S157002322100372X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S157002322100372X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T23:05:22Z","timestamp":1761606322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S157002322100372X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":58,"alternative-id":["S157002322100372X"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2021.122891","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mass spectrometry-based targeted proteomics method for the quantification of clinically relevant drug metabolizing enzymes in human specimens","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2021.122891","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"122891"}}